mnl168 info
Matt Gaetz says he won't return to Congress next year after withdrawing name for attorney general
Drones, planes or UFOs? Americans abuzz over mysterious New Jersey sightingsKANSAS CITY, Mo. — Abortion-rights advocates on Wednesday asked a judge to overturn Missouri’s near-total ban on the procedure, less than a month after voters backed an abortion-rights constitutional amendment. Jackson County Circuit Judge Jerri Zhang did not immediately rule after Wednesday’s hearing. Planned Parenthood and other plaintiffs had asked her to issue a temporary order blocking enforcement of Missouri’s numerous abortion laws. “If left in place, the above-described restrictions will continue to be catastrophic for Missourians,” lawyers for abortion-rights supporters wrote in a court brief. “They will either prevent care altogether or severely delay or interfere with care.” Several anti-abortion protesters knelt on the ground as they prayed outside the courthouse during the hearing. They covered their mouths with a red piece of tape that read “life.” Missouri is one of five states where voters approved ballot measures this year to add the right to an abortion to their state constitutions. Nevada voters also approved an amendment, but they’ll need to pass it again in 2026 for it to take effect. Another that bans discrimination on the basis of “pregnancy outcomes” prevailed in New York. Reproductive rights advocates in Arizona on Tuesday sued to undo a 15-week abortion ban that conflicts with that state's new constitutional amendment expanding access up to fetal viability. The Missouri amendment does not specifically override any state laws. Instead the measure leaves it to advocates to ask courts to knock down bans that they believe would now be unconstitutional. Missouri Attorney General Andrew Bailey, an abortion opponent, last week issued an opinion agreeing that most abortions will be legal when the amendment takes effect Thursday. But Bailey’s office is still fighting for a ban on most abortions after viability, along with a number of regulations that Planned Parenthood argues made it nearly impossible to offer abortions in the state even before abortion was almost completely banned in 2022. Missouri’s constitutional amendment allows lawmakers to restrict abortion after viability, with exceptions to “protect the life or physical or mental health of the pregnant person.” The term “viability” is used by health care providers to describe whether a pregnancy is expected to continue developing normally or whether a fetus might survive outside the uterus. Though there’s no defined time frame, doctors say it is sometime after the 21st week of pregnancy. Other abortion laws that Bailey is defending include a 72-hour waiting period before an abortion can be performed; bans on abortions based on race, sex or a possible Down syndrome diagnosis; and a requirement that medical facilities that provide abortions be licensed as ambulatory surgical centers. The Attorney General's Office argued that Planned Parenthood has not proven it will be negatively impacted by those laws, noting that no abortions have been scheduled yet. “Planned Parenthood concedes they have no appointments scheduled for right after the amendment goes into effect and have not even tried to obtain relevant licenses or create necessary complication plans,” state attorneys wrote in a court brief. It is unclear when Zhang will rule on the request for a preliminary injunction. Associated Press reporter Nick Ingram contributed to this report. Ballentine reported from Columbia, Missouri. Updated at 5:42 p.m.BMW Nerds Rejoice: The Need for Speed M3 GTR Is Now a Real Car
New GP and pharmacy announced for long-derelict Northside pub siteAP Business SummaryBrief at 4:39 p.m. EST
The China Fund, Inc. Declares Distributions"LEQEMBI®" (Lecanemab) Approved for the Treatment of Early Alzheimer's Disease in Mexico
HOUSTON--(BUSINESS WIRE)--Dec 4, 2024-- Solaris Energy Infrastructure, Inc. (NYSE:SEI) (“Solaris” or the “Company”), today announced a financial and operational update for the fourth quarter 2024 as well as updates to its growth capital program to further support the Solaris Power Solutions segment in response to rapidly evolving customer demand. Fourth Quarter 2024 Financial and Operational Update The Company is increasing its fourth quarter 2024 Adjusted EBITDA* guidance to a range of $36 million to $39 million, compared to its prior expectation for a range of $33 million to $36 million. The primary drivers behind the updated range are continued enhanced utilization levels and improved cost absorption in the Solaris Power Solutions segment. The Company expects to deploy an average of approximately 250 MW during the fourth quarter, which reflects full utilization of its currently available asset base. In its Solaris Logistics Segment, the Company expects results to be relatively in line with expectations, which should continue to support strong total company operating cash flow generation in the fourth quarter. Solaris Power Solutions Growth Capital Update The Company recently placed orders for 9 additional 16.5 megawatt (“MW”) gas-fired turbines to support rapidly accelerating customer demand, totaling approximately 145 MW in incremental generation capacity. Solaris now expects to exit first quarter 2026 with approximately 680 MW of generation capacity. The Company expects to invest up to $120 million for the new turbine order, including ancillary equipment. Additionally, the Company expects to invest approximately $40 million in Selective Catalytic Reduction (“SCR”) technology to further enhance the emissions profile of the fleet in support of multi-year installations on selected locations. This expected approximately $160 million growth capital investment should occur primarily over the course of 2025, with equipment deliveries scheduled to occur from fourth quarter 2025 through first quarter 2026. “Demand for Solaris’ power-as-a-service offering continues to exceed our available capacity, providing us with the confidence to place this additional equipment order,” commented Bill Zartler, Solaris’ Chairman and Chief Executive Officer. “Additionally, the increasing site design and engineering complexities associated with the extending tenor of our contract fixtures presents an opportunity for Solaris to offer incremental ‘balance of plant’ equipment, such as the emissions control technology, that complements our power generation offering and is expected to enhance returns. This new equipment order will provide Solaris’ customers with near-term solutions in support of some of the most demanding ‘behind-the-meter’ power applications in operation today.” Footnotes: * Non-GAAP financial measure. Please see “About Non-GAAP Measures” below. About Solaris Energy Infrastructure, Inc. Solaris Energy Infrastructure, Inc. (NYSE:SEI) provides scalable equipment-based solutions for use in distributed power generation as well as the management of raw materials used in the completion of oil and natural gas wells. Headquartered in Houston, Texas, Solaris serves multiple U.S. end markets, including energy, data centers, and other commercial and industrial sectors. Additional information is available on our website, solaris-energy.com . Forward Looking Statements This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Examples of forward-looking statements include, but are not limited to, statements with respect to the Company’s expectations of business plans, strategies, objectives and anticipated financial and operating results of the Company for the three months ending December 31, 2024, including the Company’s future profitability, expected capital expenditures and the impact of such expenditures on performance, current and potential future long-term contracts, the Company’s business and financial performance and results of operations and other guidance included in this press release, and the other risks discussed in Part I, Item 1A. “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2023 filed with the SEC on February 27, 2024 and in Part II, Item 1A. “Risk Factors” in our Quarterly Report on Form 10-Q for the quarters ended June 30, 2024 and September 30, 2024 filed with the SEC on August 9, 2024 and November 7, 2024, respectively. Forward-looking statements are based on our current expectations and assumptions regarding our business, the economy and other future conditions. Because forward-looking statements relate to the future, by their nature, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. As a result, our actual results may differ materially from those contemplated by the forward-looking statements. Factors that could cause our actual results to differ materially from the results contemplated by such forward-looking statements include, but are not limited to the factors discussed or referenced in our filings made from time to time with the SEC. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date hereof. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law. About Non-GAAP Measures Management believes that Adjusted EBITDA provides useful information to investors regarding the Company’s financial condition and results of operations because it reflects the core operating results of the Company’s businesses and helps facilitate comparisons of operating performance across periods. We define EBITDA as net income, plus (i) depreciation and amortization expense, (ii) interest expense and (iii) income tax expense. We define Adjusted EBITDA as EBITDA plus (i) stock-based compensation expense and (ii) certain non-cash items and extraordinary, unusual or non-recurring gains, losses or expenses. Although management believes the aforementioned non-GAAP financial measure is a good tool for internal use and the investment community in evaluating Solaris’s overall financial performance, the foregoing non-GAAP financial measure should be considered in addition to, not as a substitute for or superior to, other measures of financial performance prepared in accordance with GAAP. However, no reconciliations of this non-GAAP measure to its most directly comparable GAAP measure is available without unreasonable efforts. This is due to the inherent difficulty of forecasting the timing or amount of various reconciling items that would impact the most directly comparable forward-looking GAAP financial measure, that have not yet occurred, are out of our control and/or cannot be reasonably predicted given we have not completed any reporting processes for the period presented. Preliminary Estimate This press release provides a preliminary estimate of our Adjusted EBITDA for the three months ending December 31, 2024. This preliminary estimate is derived from our internal records and is based on the most current information available to management. Our normal reporting processes with respect to the foregoing preliminary estimate have not been fully completed and, during the course of our review process on this preliminary estimate, we could identify items that would require us to make adjustments and which could affect our final results. Any such adjustments could be material. This preliminary estimate has not been audited or reviewed by our independent auditors nor have our independent auditors performed any procedures with respect to this information or expressed any opinion or any form of assurance on such information. View source version on businesswire.com : https://www.businesswire.com/news/home/20241204678559/en/ CONTACT: Yvonne Fletcher Senior Vice President, Finance and Investor Relations (281) 501-3070 IR@solaris-energy.com KEYWORD: UNITED STATES NORTH AMERICA TEXAS INDUSTRY KEYWORD: ENGINEERING OTHER ENERGY UTILITIES OIL/GAS MANUFACTURING ENERGY MACHINERY SOURCE: Solaris Energy Infrastructure, Inc. Copyright Business Wire 2024. PUB: 12/04/2024 06:29 PM/DISC: 12/04/2024 06:28 PM http://www.businesswire.com/news/home/20241204678559/enUndercover FBI agents had no role in US Capitol attack: report
Union Pacific Corporation Declares Fourth Quarter 2024 Dividend
By MIKE FITZPATRICK AP Sports Writer NEW YORK — Same iconic statue, very different race. With two-way star Travis Hunter of Colorado and Boise State running back Ashton Jeanty leading the field, these certainly aren’t your typical Heisman Trophy contenders. Sure, veteran quarterbacks Dillon Gabriel from top-ranked Oregon and Cam Ward of No. 15 Miami are finalists for college football’s most prestigious award as well, but the 90th annual ceremony coming up Saturday night at Lincoln Center in New York City (5 p.m. PT, ESPN) offers a fresh flavor this year. To start with, none of the four are from the powerhouse Southeastern Conference, which has produced four of the past five Heisman winners – two each from Alabama and LSU. Jeanty, who played his home games for a Group of Five team on that peculiar blue turf in Idaho more than 2,100 miles from Manhattan, is the first running back even invited to the Heisman party since 2017. After leading the country with 2,497 yards rushing and 29 touchdowns, he joined quarterback Kellen Moore (2010) as the only Boise State players to be named a finalist. “The running back position has been overlooked for a while now,” said Jeanty, who plans to enter the 2025 NFL Draft. “There’s been a lot of great running backs before me that should have been here in New York, so to kind of carry on the legacy of the running back position I think is great. ... I feel as if I’m representing the whole position.” With the votes already in, all four finalists spent Friday conducting interviews and sightseeing in the Big Apple. They were given custom, commemorative watches to mark their achievement. “I’m not a watch guy, but I like it,” said Hunter, flashing a smile. The players also took photos beneath the massive billboards in Times Square and later posed with the famous Heisman Trophy, handed out since 1935 to the nation’s most outstanding performer. Hunter, the heavy favorite, made sure not to touch it yet. A dominant player on both offense and defense who rarely comes off the field, the wide receiver/cornerback is a throwback to generations gone by and the first full-time, true two-way star in decades. On offense, he had 92 catches for 1,152 yards and 14 touchdowns this season to help the 20th-ranked Buffaloes (9-3) earn their first bowl bid in four years. On defense, he made four interceptions, broke up 11 passes and forced a critical fumble that secured an overtime victory against Baylor. Hunter played 688 defensive snaps and 672 more on offense – the only Power Four conference player with 30-plus snaps on both sides of the ball, according to Colorado research. Call him college football’s answer to baseball unicorn Shohei Ohtani. “I think I laid the ground for more people to come in and go two ways,” Hunter said. “It starts with your mindset. If you believe you can do it, then you’ll be able to do it. And also, I do a lot of treatment. I keep up with my body. I get a lot of recovery.” Hunter is Colorado’s first Heisman finalist in 30 years. The junior from Suwanee, Georgia, followed Coach Deion Sanders from Jackson State, an HBCU that plays in the lower level FCS, to the Rocky Mountains and has already racked up a staggering combination of accolades this week, including The Associated Press Player of the Year. Hunter also won the Walter Camp Award as national player of the year, along with the Chuck Bednarik Award as the top defensive player and the Biletnikoff Award for best wide receiver. “It just goes to show that I did what I had to do,” Hunter said. Next, he’d like to polish off his impressive hardware collection by becoming the second Heisman Trophy recipient in Buffaloes history, after late running back Rashaan Salaam in 1994. “I worked so hard for this moment, so securing the Heisman definitely would set my legacy in college football,” Hunter said. “Being here now is like a dream come true.” Jeanty carried No. 8 Boise State (12-1) to a Mountain West Conference championship that landed the Broncos the third seed in this year’s College Football Playoff. They have a first-round bye before facing the SMU-Penn State winner in the Fiesta Bowl quarterfinal on New Year’s Eve. The 5-foot-9, 215-pound junior from Jacksonville, Florida, won the Maxwell Award as college football’s top player and the Doak Walker Award for best running back. Jeanty has five touchdown runs of at least 70 yards and has rushed for the fourth-most yards in a season in FBS history – topping the total of 115 teams this year. He needs 132 yards to break the FBS record set by Heisman Trophy winner Barry Sanders at Oklahoma State in 1988. In a pass-happy era, however, Jeanty is trying to become the first running back to win the Heisman Trophy since Derrick Henry for Alabama nine years ago. In fact, quarterbacks have snagged the prize all but four times this century. Gabriel, an Oklahoma transfer, led Oregon (13-0) to a Big Ten title in its first season in the league and the No. 1 seed in the College Football Playoff. The steady senior from Hawaii passed for 3,558 yards and 28 touchdowns with six interceptions. His 73.2% completion rate ranks second in the nation, and he’s attempting to join quarterback Marcus Mariota (2014) as Ducks players to win the Heisman Trophy. “I think all the memories start to roll back in your mind,” Gabriel said. Ward threw for 4,123 yards and led the nation with a school-record 36 touchdown passes for the high-scoring Hurricanes (10-2) after transferring from Washington State. The senior from West Columbia, Texas, won the Davey O’Brien National Quarterback of the Year award and is looking to join QBs Vinny Testaverde (1986) and Gino Torretta (1992) as Miami players to go home with the Heisman. “I just think there’s a recklessness that you have to play with at the quarterback position,” Ward said. Finalists: QB Dillon Gabriel, Oregon; WR/CB Travis Hunter, Colorado; RB Ashton Jeanty, Boise State; QB Cam Ward, Miami When: Saturday, 5 p.m. PT Where: Lincoln Center, New York City TV: ESPNNone
Trump’s latest tariff plan aims at multiple countries. What does it mean for the US?GEORGETOWN, Ky. (AP) — Toyota said Thursday it will build a new paint facility as part of a $922 million investment at its factory complex in Georgetown, Kentucky, making it the second big addition announced this year at the automaker’s largest global manufacturing plant. In February, the company said it would at its Kentucky complex, in part so it can build an all-new three-row electric SUV to be sold in the U.S. Neither project will add any new jobs at the facility, which now employs about 10,000 workers. However, the investments reinforce Toyota’s commitment to long-term job stability, the company said. The new paint facility, scheduled to open in 2027, will add 1 million square feet of capacity while decreasing carbon emissions by 30% and water usage by 1.5 million gallons per year, Toyota said. It will enable the company to offer more diverse color options for its vehicles, the company said. “Toyota’s commitment to advanced paint technologies goes beyond aesthetics,” said Kerry Creech, president of Toyota Kentucky. “It encompasses efficiency, sustainability and quality, leading the industry in environmentally responsible manufacturing.” The project also will increase flexibility for future vehicle production and advances Toyota’s goal to achieve zero carbon emissions by 2050, the automaker said. Toyota’s investment in the Bluegrass State has surpassed $11 billion since breaking ground at the central Kentucky site in 1986. Georgetown is 16 miles (26 kilometers) north of Lexington, Kentucky. The Associated Press
Charles attended the show at the Royal Albert Hall in London for the first time as patron of the Royal Variety charity, following in the footsteps of his mother, the late Queen Elizabeth II. In a statement from Buckingham Palace, he said: “The charity’s crucial work in assisting those who have fallen ill, had an accident or hit hard times is as essential now as it ever has been. “I would like to thank all of those who have worked so hard to stage this year’s production and wish everyone a very enjoyable evening.” The performance saw political comic Forde reference the unfounded claims Mr Trump repeated during his presidential debate against Democrat candidate Kamala Harris earlier this year, that illegal immigrants from Haiti were eating locals’ pets in the small Ohio city of Springfield. Forde exclaimed in the president-elect’s voice: “They’re eating the cats, they’re eating the dogs!” He then turned to address Charles from the stage, saying in Mr Trump’s voice: “Your Majesty King Charles, you’re named after a spaniel – be very careful, they’ll eat you alive.” The King was seen laughing in response to the joke from the royal box. Charles appeared at the event without the Queen, who insisted the “show must go on” after pulling out of attending the performance on Friday evening as doctors advised that she should prioritise rest. A Buckingham Palace spokesperson said: “Following a recent chest infection, the Queen continues to experience some lingering post-viral symptoms, as a result of which doctors have advised that, after a busy week of engagements, Her Majesty should prioritise sufficient rest. “With great regret, she has therefore withdrawn from attendance at tonight’s Royal Variety Performance. His Majesty will attend as planned.” A royal source said the Queen was “naturally disappointed to miss the evening’s entertainments and sends her sincere apologies to all those involved, but is a great believer that ‘the show must go on'”. “She hopes to be back to full strength and regular public duties very soon,” the source added. The Royal Variety Performance will air on ITV1, ITVX, STV and STV Player in December. Money raised from the show will go to help people from the world of entertainment in need of care and assistance, with the Royal Variety Charity launching an initiative to help those with mental health issues this year.
From Pride employee resource groups to a recurring wave of rainbow logos each June, LGBTQ+-friendly workplaces can feel more like the rule than the exception in 2024. Yet, while corporate leaders pat themselves on the back, many queer employees across Canada are still quietly navigating challenging workplace dynamics tied to their sexual orientations and gender identities. For these employees, true equity and inclusivity goes beyond gender-neutral bathrooms and company-sponsored Pride events. It means addressing deeper, often overlooked issues that remain largely invisible to those outside the LGBTQ+ community. It’s an issue that Nate Shalev, an inclusivity speaker and adviser based in Brooklyn, N.Y., feels strongly about. They posted about some of those barriers in a LinkedIn post, where they are ranked as one of the U.S. and Canada’s Top LGBTQIA+ Voices. “When I was told I would have to travel for work, my immediate reaction would be panic,” they wrote. “I was concerned about booking travel with my legal name and risking my team calling me by a name I no longer use, getting through TSA as a trans person with my dignity intact ... [and] navigating queer and transphobia at hotels or in taxis, or anywhere, in front of my co-workers.” Through their consultancy, Revel Impact, Shalev draws on past experiences with “really bad bosses” to help build more inclusive workplaces, educating companies on the barriers their LGBTQ+ team members may be facing – on top of simply getting their jobs done. Barriers like: “Is the conference you asked me to go to safe? What about that client meeting? The whole team is going for a happy hour, but this bar isn’t LGBTQ-friendly. Should I leave? Would that make me look like I wasn’t a part of the team?” Shalev says these sorts of concerns are routinely dismissed or there’s no clear channel through which to handle them since they don’t rise to a legal level of discrimination, despite having negative affects. While most organizations in North America have anti-discrimination policies in place, Ottawa-based talent and brand specialist Lindsay Moorcroft says that doesn’t necessarily mean those policies are sufficient. “Unless you’re building your programs and policies with the [affected] people in the room, there’s always the possibility for something to be forgotten,” Moorcroft says, reflecting on a previous job at a small startup where she was the only out queer employee. “Pronouns weren’t being asked in meetings. They weren’t shared in e-mail signatures. There was no option to even talk about that. So then it’s like, do I want to be the person who brings it up?” she says. For Kaitlin Geiger-Bardswich, a communications and advocacy director in Ottawa, the risk of speaking up paid off. Although she works for a national non-profit she calls “progressive” and “feminist,” bereavement leave didn’t include pregnancy loss until she advocated for it after experiencing a miscarriage herself. “Even if it’s not a miscarriage, when a fertility treatment doesn’t work, when an embryo transfer doesn’t work, there is that grief,” she says. Fertility issues aren’t specific to the LGBTQ+ community, but “gay couples, by definition, typically need to access fertility treatment of some kind,” as Geiger-Bardswich says. “So it’s more likely that if you have gay employees who are interested in parenting, they’re going to have to navigate this.” According to Fertility Matters Canada , more than half of Canadian employers don’t provide fertility benefits, including drugs and treatment costs. And only seven provinces provide public funding to cover partial costs of fertility treatment. In Geiger-Bardswich’s case, she and her wife relied on limited OHIP coverage when trying to conceive, while paying thousands of dollars out-of-pocket for medication and donor sperm. She says she was grateful to have flexibility in her work hours, which made it easier to attend doctor’s appointments throughout the in-vitro fertilization process without fear of repercussions. Flexible work arrangements, including remote work, can also benefit transgender employees who are transitioning or who are repeatedly misgendered at the office, says Shalev. Geiger-Bardswich notes that as anti-trans and anti-LGBTQ+ rhetoric increases around the world, it adds another layer of concern for queer Canadians. She points to Italy’s push to remove non-biological parents from birth certificates as an example. “I hope that’s not going to happen in Canada,” she says. “But with how things are happening around the world, there is nervousness around the legal benefits and legal situations for parents like us.” So, what can workplaces do to achieve real, meaningful inclusivity? Shalev says it’s about taking a pro-active, rather than reactive, approach. This could look like ensuring there’s space for preferred names on all applications, forms and other communications. Before international trips, a systematic pretravel questionnaire might allow queer employees to request extra security, a travel companion, a NEXUS membership or a car service to make the experience safer and smoother, Shalev says. “It doesn’t have to feel complicated. Actively create spaces for these conversations to happen. Ask folks what they need,” says Shalev, noting that this has been more difficult in recent years with LGBTQ+ issues growing increasingly politicized. “Because queer issues have been politicized so much, there’s this sense that it’s a taboo topic. That’s a big shift I’ve seen, versus it just being inclusion work and wanting to support colleagues. Trans folks aren’t politics. We’re people.” One organization that appears to be embracing a pro-active approach is Moorcroft’s current employer, ecobee, a home automation company headquartered in Toronto. The company’s diversity, equity and inclusion (DEI) offerings include an LGBTQ+ allyship group, a private social channel for LGBTQ+ employees and a policy-focused working group. Most importantly, Moorcroft says, a variety of voices are in these rooms alongside her, including those of senior leadership. “DEI means nothing if the top of the company is not supporting it, and it’s not in their [budget],” she says. Every organization has different needs and resources, which is why Shalev says, “It’s not one-size-fits-all.” Pride at Work Canada and Great Place to Work provide toolkits for organizations looking to improve inclusion, with strategies ranging from collecting data on employee demographics to administering queer mentorship programs. While certain measures may seem niche, “LGBTQ+ inclusion benefits us all,” Shalev says. “When I do workshops, of course I know there are other queer folks in the room. But then there are the parents of trans kids, or somebody with a partner who’s trans. Our workplaces are microcosms of our larger society, and if we create better workplaces, we can also create better communities and [and better] worlds.” Interested in more perspectives about women in the workplace? Find all stories on The Globe Women’s Collective hub here , and subscribe to the new Women and Work newsletter here . Have feedback? E-mail us at [email protected] .
ARSENAL put in a sublime away performance to beat Sporting 5-1. The Gunners dominated the first 45 minutes and were excellent as the Portuguese giants failed to lay a glove on them. Gabriel Martinelli, Kai Havertz and Gabriel were amongst the goals in a brilliant first-half from Mikel Arteta's side. But Sporting upped it after the break and got a goal back - only for Arsenal to show their class and manage the game well as Bukayo Saka and Leandro Trossard put the game to bed. Here is how SunSport rated the Arsenal players' performances. David Raya - 6 Did not have much to do besides a save from Morten Hjulmund. Good distribution and catches from crosses. Jurrien Timber - 8 A great low cross into the box for Arsenal's opener. Very solid at right-back all game. FOOTBALL FREE BETS AND SIGN UP DEALS William Saliba - 7 Dealt with Viktor Gyokeres well. Did not get drawn into fouling him and held his ground before timing the tackle well. Gabriel - 8 Scored his trademark back-post crashing goal from a corner. A great leap and powerful header once again. Defended Gyokeres by being physical and on the front foot against him. But the tactic led to giving away a cheap free-kick in a dangerous area that went unpunished. Riccardo Calafiori - 5 Sporting attacked a lot down Arsenal's left in the first-half and Francisco Trincao caused him a few issues. Lost his man and ended up on the deck as Goncalo Inacio headed in from a corner. Thomas Partey - 8 A sensational ball over the top of the Sporting defence to put Saka through on goal for the second. Was a real calming influence in possession. Declan Rice - 6 His first game back from injury. Was perhaps the reason why his display was not as good as usual and was taken off early. Fantastic delivery for the corner. Martin Odegaard - 9 Pulls the strings for the Gunners and has the ability to pick passes that carve open defences from the edge of the box, particularly combining well with Saka. Such a huge difference between performances with and without him in the team. Absolutely incredible. Bukayo Saka - 8 Simply brilliant. A constant threat down the right as always, twisting and turning defenders inside out. His penalty was exceptional and came at a time when Arsenal were a little up against it. Whipped into the inside side netting. Kai Havertz - 8 Was in the right place at the right time for the goal. Intelligent runs and movement from him as he often dropped deep to receive the ball. Gabriel Martinelli - 7 Was incredibly lively in the opening period, working hard defensively and causing Sporting a problem with his directness. Good movement for the goal, going on the blind side of defender Geovany Quenda. But Martinelli faded and did very little after a positive start. Subs: Leandro Trossard (for Martinelli, 70 mins) - 7 Scored the fifth goal. Another in the right place as the ball dropped. Mikel Merino (for Rice, 70 minutes) - 7 Assured cameo in midfield. Oleksandr Zinchenko (for Calafiori, 78 minutes) - 6 Calm on the ball after coming on. Ethan Nwaneri (for Odegaard, 78 minutes) - 6 Oozes class and came close to scoring/ Jakub Kiwior (for Gabriel, 84 minutes) - 5 Got done by the pace of Gyokeres in the latter stages.John Kerry warns US is 'on the brink' of declaring a climate emergency
Hakeem Jeffries: Nancy Mace 'Clearly Needs an Intervention'
By Michelle Marchante, Miami Herald (TNS) MIAMI — As her students finished their online exam, Arlet Lara got up to make a cafe con leche . Her 16-year-old son found her on the kitchen floor. First, he called Dad in a panic. Then 911. “I had a stroke and my life made a 180-degree turn,” Lara told the Miami Herald, recalling the medical scare she experienced in May 2020 in the early months of the COVID pandemic. “The stroke affected my left side of the body,” the North Miami woman and former high school math teacher said. Lara, an avid runner and gym goer, couldn’t even walk. “It was hard,” the 50-year-old mom said. After years of rehabilitation therapy and a foot surgery, Lara can walk again. But she still struggles with moving. This summer, she became the first patient in South Florida to get an implant of a new and only FDA-approved nerve stimulation device designed to help ischemic stroke survivors regain movement in their arms and hands. This first procedure was at Jackson Memorial Hospital in Miami. Lara’s rehab was at at the Christine E. Lynn Rehabilitation Center for The Miami Project to Cure Paralysis, part of a partnership between Jackson Health System and UHealth. Every year, thousands in the United States have a stroke , with one occurring every 40 seconds, according to the U.S. Centers for Disease Control and Prevention. The majority of strokes are ischemic, often caused by blood clots that obstruct blood flow to the brain. For survivors, most of whom are left with some level of disability, the Vivistim Paired VNS System, the device implanted in Lara’s chest, could be a game changer in recovery, said Dr. Robert Starke, a UHealth neurosurgeon and interventional neuroradiologist. He also serves as co-director of endovascular neurosurgery at Jackson Memorial Hospital, part of Miami-Dade’s public hospital system. Arlet Lara, the first patient in South Florida to get an FDA-approved nerve stimulation implant, right, runs into her rehabilitation neurology physician Dr. Gemayaret Alvarez, before her physical therapy appointment on Monday, Sept. 9, 2024, at Lynn Rehabilitation Center at Jackson Memorial Hospital. The implant is designed to help stroke survivors regain function in their arms. (Alie Skowronski/Miami Herald/TNS) Arlet Lara, the first patient in South Florida to get an FDA-approved nerve stimulation implant designed to help stroke survivors regain function in their arms, goes through exercises while her therapist activates the device during her physical therapy appointment on Monday, Sept. 9, 2024, at Lynn Rehabilitation Center at Jackson Memorial Hospital. The activation works as positive reinforcement to her muscles when she completes the exercise correctly. (Alie Skowronski/Miami Herald/TNS) Arlet Lara, the first patient in South Florida to get an FDA-approved nerve stimulation implant, does an exercise while Neil Batungbakal, rehabilitation therapist, activates the implant with the black trigger during her physical therapy appointment on Monday, Sept. 9, 2024, at Lynn Rehabilitation Center at Jackson Memorial Hospital. The implant is designed to help stroke survivors regain function in their arms. The activation works as positive reinforcement to her muscles when she completes the exercise correctly. (Alie Skowronski/Miami Herald/TNS) Arlet Lara, the first patient in South Florida to get an FDA- approved nerve stimulation implant, does an exercise while Neil Batungbakal, rehabilitation therapist, activates the implant with the black trigger during her physical therapy appointment on Monday, Sept. 9, 2024, at Lynn Rehabilitation Center at Jackson Memorial Hospital. Arlet Lara, the first patient in South Florida to get an FDA-approved nerve stimulation implant, right, runs into her rehabilitation neurology physician Dr. Gemayaret Alvarez, before her physical therapy appointment on Monday, Sept. 9, 2024, at Lynn Rehabilitation Center at Jackson Memorial Hospital. The implant is designed to help stroke survivors regain function in their arms. (Alie Skowronski/Miami Herald/TNS) What to know about the stroke device The Vivistim Paired VNS System is a small pacemaker-like device implanted in the upper chest and neck area. Patients can go home the same day. The U.S. Food and Drug Administration approved the stroke rehabilitation system in 2021 to be used alongside post-ischemic stroke rehabilitation therapy to treat moderate to severe mobility issues in hands and arms. Lara’s occupational therapist can activate the device during rehabilitation sessions to electrically stimulate the vagus nerve, which runs from the brain down to the abdomen and regulates various parts of the body’s nervous system. The electrical stimulation rewires the brain to improve a stroke survivor’s ability to move their arms and hands. How it worked on the first Jackson patient Lara also has a magnet she can use to activate the device when she wants to practice at home. Her therapy consists of repetitive tasks, including coloring, pinching cubes and grabbing and releasing cylindrical shapes. After several weeks of rehabilitation therapy with the device, Lara has seen improvement. “Little by little, I’m noticing that my hand is getting stronger. I am already able to brush my teeth with the left hand,” she told the Miami Herald in September. Since then, Lara has finished the initial six-week Vivitism therapy program, and is continuing to use the device in her rehabilitation therapy. She continues to improve and can now eat better with her left hand and can brush her hair with less difficulty, according to her occupational therapist, Neil Batungbakal. Lara learned about the device through an online group for stroke survivors and contacted the company to inquire. She then connected them with her Jackson medical team. Now a year later, the device is available to Jackson patients. So far, four patients have received the implant at Jackson. Related Articles Health | Washington power has shifted. Here’s how the ACA may shift, too Health | CDC chief urges focus on health threats as agency confronts political changes Health | New rule allows HIV-positive organ transplants Health | Biden proposes Medicare and Medicaid cover costly weight-loss drugs for millions of obese Americans Health | Do not wash your turkey and other Thanksgiving tips to keep your food safe Starke sees the device as an opportunity to help bring survivors one step closer to regaining full mobility. Strokes are a leading cause of disability worldwide. While most stroke survivors can usually recover some function through treatment and rehabilitation, they tend to hit a “major plateau” after the first six months of recovery, he said. Vivistim, when paired with rehabilitation therapy, could change that. Jackson Health said results of a clinical trial published in the peer-reviewed medical journal The Lancet in 2021 showed that the device, “when paired with high-repetition, task-specific occupational or physical therapy, helps generate two to three times more hand and arm function for stroke survivors than rehabilitation therapy alone.” The device has even shown to benefit patients 20 years from their original stroke, according to Starke. “So now a lot of these patients that had strokes 10-15 years ago that thought that they would never be able to use their arm in any sort of real functional way are now able to have a real meaningful function, which is pretty tremendous,” Starke said. More about the device Vivistim’s vagus-nerve stimulation technology was developed by researchers at the University of Texas at Dallas’ Texas Biomedical Device Center and is being sold commercially by Austin-based MicroTransponder, a company started by university graduates. Similar devices are used to treat epilepsy and depression . For Lara, the device is a new tool to help her recovery journey. “Everything becomes a challenge so we are working with small things every day because I want to get back as many functions as possible,” Lara said. Patients interested in Vivistim should speak with their doctor to check their eligibility. The FDA said patients should make sure to discuss any prior medical history, including concurrent forms of brain stimulation, current diathermy treatment, previous brain surgery, depression, respiratory diseases and disorders such as asthma, and cardiac abnormalities. “Adverse events included but were not limited to dysphonia (difficulty speaking), bruising, falling, general hoarseness, general pain, hoarseness after surgery, low mood, muscle pain, fracture, headache, rash, dizziness, throat irritation, urinary tract infection and fatigue,” the FDA said. MicroTransponder says the device is “covered by Medicare, Medicaid, and private insurance with prior authorization on a case-by-case basis.” To learn more about the device, visit vivistim.com. ©2024 Miami Herald. Visit at miamiherald.com. Distributed by Tribune Content Agency, LLC.
Australia v India third Test LIVE updates: Hot, humid conditions await at the Gabba